Health Care: Drugs

Corcept Therapeutics Inc (CORT: NASDAQ)

$11.46 -0.67 | -5.52%
05/25/17 - 02:31 PM ET
Company Profile
Price and Volume
Recent Price 12.13
52 Week High 12.40
52 Week Low 4.95
Avg. Daily Vol. (Mil) 1.04
Beta (3 year) 1.35
Share Related Items
Mkt Cap (Mil) 1,372.96
Shares Out (Mil) 113.19
Float (Mil) 82.90
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.40
Current Ratio 2.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.20
Valuation Ratios
Price Earnings 110.30
Price/Sales 14.79
Price/Book 27.69
Price/Cash Flow 96.30
Per Share Data
Earnings 0.11
Sales 0.82
Book Value 0.44
Cash Flow 0.13
Business Summary
Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.
General Information
149 Commonwealth Drive
Menlo Park, CA 94025
www.corcept.com
Industry : Drugs
Sector: Health Care
Employees: 103
CEO: Joseph K. Belanoff,M.D.
Short Interest
Current Month (Mil) 6.82
Previous Month (Mil) 6.33
Short Interest Ratio (Days) 7.10
Management Effectiveness
Return on Equity 25.30
Return on Assets 16.70
Return on Investments 25.30
Profitability
Gross Margin 99.40
EBIT Margin 15.40
Profit Margin 13.50

Portfolios with CORT

Latest CORT Headlines from TheStreet

More Financial News for CORT

Press Releases for CORT

See All Press Releases

Partner Headlines for CORT

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter